Wolfe Research Maintains Moderna(MRNA.US) With Sell Rating, Cuts Target Price to $25
Wolfe Research Cuts Moderna Price Target to $25 From $35
Needham Maintains Moderna(MRNA.US) With Hold Rating
TD Cowen Maintains Moderna(MRNA.US) With Hold Rating, Cuts Target Price to $35
Moderna Is Maintained at Underperform by B of A Securities
Moderna Analyst Ratings
Bernstein Maintains Moderna(MRNA.US) With Hold Rating, Cuts Target Price to $45
Moderna Cut to Neutral From Buy by Goldman Sachs
Moderna Analyst Ratings
Goldman Sachs Downgrades Moderna(MRNA.US) to Hold Rating, Cuts Target Price to $51
Goldman Sachs Maintains Moderna(MRNA.US) With Buy Rating, Cuts Target Price to $99
J.P. Morgan Maintains Moderna(MRNA.US) With Sell Rating, Announces Target Price $40
Moderna Is Maintained at In-Line by Evercore ISI Group
Moderna Analyst Ratings
Evercore Maintains Moderna(MRNA.US) With Hold Rating, Cuts Target Price to $50
Goldman Sachs Adjusts Price Target on Moderna to $99 From $112, Keeps Buy Rating
Morgan Stanley Maintains Moderna(MRNA.US) With Hold Rating, Maintains Target Price $38
Piper Sandler Maintains Moderna(MRNA.US) With Buy Rating, Maintains Target Price $69
Moderna Is Maintained at Equal-Weight by Morgan Stanley
Moderna Analyst Ratings